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therapy, and in many cases these are grossly ill-equipped
and lack adequately trained personnel.
In response to this upcoming crisis, the Department of
Medical Physics and Bioengineering at UCL along with
the Radiotherapy Departments at the Royal Berkshire
Hospital (RBH) and UCL Hospital have formed a global
health initiative called paRTner. Our aim is to apply the
resources and expertise for cancer treatment that we have
in the UK to accelerate the development of radiotherapy
services in developing countries. In May 2012 a team
supported by UCL Friends visited Ghana to identify both
short- and long-term needs in their radiotherapy service.
On this trip we found a small group of radiotherapy
staff who were hard working and dedicated but who
lacked the necessary level of training to optimise the
service or to develop it in the future. A particularly
significant area is a shortage of skilled engineers, leading
n the developing countries of Africa cancer is of
alarming concern: 
n The World Health Organization predicts that by
2017 cancer’s death toll in Africa will exceed that of
HIV/AIDS, tuberculosis and malaria combined. 
n Cancer rates in Africa are expected to double by 2030.
n Most African countries have less than 5 per cent of
the total radiotherapy provision necessary.
n Africa has a population 17 times that of the UK yet
only has twice as many trained healthcare workers.
n 80 per cent of cancer patients in Africa are diagnosed
at such a late stage that only palliative treatment is
possible and many die before the treatment is complete.
Many receive no treatment.
Over half of all cancer patients require radiation
treatment during the course of their disease. Only a few
countries in Africa have any facilities for radiation
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to significant downtime in service provision; a fact
strongly expressed by Dr Joel Yarney, the head of Ghana’s
oncology programme. There is no routine preventative
maintenance, meaning that there are frequent
breakdowns that take on average 3 weeks to fix. This is
largely because departments do not stock spare parts,
and need to request funding from management for each
repair. At the time of our visit one of the two cancer
centres had been unable to treat breast cancer patients for
the previous 3 weeks due to a relatively minor equipment
fault and insufficient local knowledge to repair it. This
will have had a catastrophic impact on the patients about
to embark upon or part-way through their treatment
regime, estimated to be in the region of 100 patients. 
They have dedicated staff who are constantly battling
officialdom as well as local beliefs. Meeting with Ghana’s two
senior medical physicists was a humbling experience and makes
me realise what relative luxuries we have in the health service
here. The challenges we face pale into insignificance compared
to what they see every day. They still have some enormous
problems to overcome but their attitude and approach acts as an
example to us all. Derek D’Souza, Head of Radiotherapy
Physics, UCLH
Cancer landscape in Ghana
Cancer in Ghana is largely diagnosed at a late stage and
viewed as a death sentence. Survival rates are estimated
to be in the region of 30 per cent for most cancers,
compared to 80–90 per cent for the same cancers in the
UK. Sixty per cent of Ghanaian women diagnosed with
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breast cancer are in stage III or IV.1 This is in great
discrepancy to English rates, where a 2012 study found
that only around 14 per cent of cases were this
advanced.2 Ghanaian cancer centres also treat cancers
not typically seen any more in UK centres. Many of the
cancers presented in Ghana are caused by viruses and
thus could be prevented with national vaccination
programmes. For example, cervical cancer is highly
prevalent due to the lack of a cervical screening
programme and no nationwide HPV vaccination
programme in Ghana. Hepatitis B and C vaccines can
protect against the ~80 per cent of liver cancers
attributable to the hepatitis virus; the geographical
variability of the virus maps precisely to the prevalence
of liver cancer globally. There is also a relation between
the incidence of Epstein Barr virus (EBV) and the
mortality rates of Burkitt lymphoma, the most common
childhood cancer in Ghana. Introduction of screening
programmes could also impact on early detection rates;
advanced screening techniques requiring specialist
equipment could be replaced with solutions more
suited to the developing world.
Ghana has a population of 25 million people and has
a cancer treatment catchment population of nearly 50
million which includes the dependent neighbouring
countries of Burkina Faso and Togo. According to
international guidelines this population requires >100
radiotherapy treatment units. Currently Ghana can
boast of only two cobalt-60 units, one in each of the
publicly owned radiotherapy centres: the National
Centre for Radiotherapy and Nuclear Medicine, ‰
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Placing cancer services within cultural context
The attitude of the Ghanaian population towards cancer
is very different to that in the UK, and high importance
should be placed on understanding cancer in its cultural
context in order to tackle the root causes of late
presentation. Within a populous which subscribes to
traditional African religious beliefs where practising
‘magic’ or ‘juju’ is commonplace, cancer is perceived as
the result of a curse, or a punishment from God, thereby
attaching a huge stigma to cancer sufferers and their
families. Understandably many people do not want to
admit to having cancer as they risk social rejection, and
seek treatment too late. Within the local belief system, it is
logical to fight ‘magic’ with ‘magic’ and many therefore
opt to seek help from traditional healers (a cheaper and
more discrete alternative to hospital treatment); one
study found that herbal medicine or attending prayer
camps was the reason for 40 per cent of patients delaying
treatment.1 Some typical responses in a study about the
Ghanaian public’s view of cancer were: 
You get treated and still die. 
By saying the word ‘cancer’ you are ‘inviting’ or ‘bringing’
cancer into your life.
Breast cancer is caused by violence, injury and sex.3
It is widely believed that cancer is an incurable
disease, which has contributed to Ghana’s National
Health Insurance Scheme (NHIS) not covering cancer
treatment. Cancer treatment in Ghana typically costs
£300–500, a typical annual income for most of the
population; 27 per cent are living on less than £1 per day. 
There is a surprising lack of awareness of cancer
amongst the population. There is almost no cancer
information available and very limited education. A
locally run Cancer Awareness Programme is underway to
Korle-Bu Teaching Hospital (KBTH), Accra, and the
Oncology Directorate, Komfo Anokye Teaching Hospital
(KATH), Kumasi, established in 1997 and 2004,
respectively. These centres each employ one qualified
radiotherapy physicist, two oncologists and three
radiographers. In addition to the two cobalt-60 units,
Ghana currently operates two caesium-137 low dose rate
brachytherapy units, an orthovoltage unit and a
simulator. A third radiotherapy centre called
Sweden–Ghana Medical Centre, which is privately
owned, is also up and running. The Ghanaian
government, under the recommendations of the
International Atomic Energy Authority (IAEA), is starting
to address the situation and is investing over £10 million
to buy a further three treatment machines. Two of these
machines will be linear accelerators, although at present
there is no linac expertise in the country. 
Ghana can expect about 62,500 new cancer patients
per annum. According to the International Agency for
Research on Cancers, more than 35,000 of these cases
would require radiotherapy. The three centres altogether
annually treat less than 5,000 new cancer cases, leaving a
shortfall of more than 30,000 incidences. There is
therefore a huge gap that should be filled by government
and stakeholders with support from international bodies
and a need to build human capacity in radiation
oncology such as oncologists, medical physicists,
radiotherapists and therapy radiographers.
In Ghana there is a need for more staff with specialised hands-
on training in radiotherapy. Many staff have a theoretical
understanding but very little practical knowledge. A training
programme will enable Ghanaian professionals to update their
skills to the international professional standards in order to
confidently handle different areas of radiotherapy. James
Annkah, paRTner coordinator in Ghana
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inform the public about symptoms, but the materials
produced only display very late effects of cancer and
so early symptoms continue to be missed. 
Work has started to address late presentation within
this cultural context and to remove the social stigma
placed on cancer patients; Eric Addison and his co-
workers at KATH visit churches on Sundays to
educate the congregation about the medical causes of
cancer. Pastors are encouraged to help disband
erroneous beliefs and attitudes towards cancer and
those afflicted with it. Medical physicists have also
hosted training sessions aimed at traditional healers to
assist them in diagnosing cancer and to set up working
partnerships between the traditional and Western
medicine techniques to allow for a more holistic,
workable solution to cancer treatment. paRTner is also
supporting efforts to boost cancer awareness; Mary
Neal from UCL has established an educational link
with Ghanaian high schools and will tour Ghana this
summer to teach 15–17 year olds about the causes and
symptoms of cancer.
Hurdles to overcome
There are groups who dispute the introduction of linac
technology to developing nations; concerns of unstable
power supplies and incapacity to deal with machine
breakdowns are but a few reasons that development
has been quashed so far. Indeed, access to spare parts
and engineers sufficiently trained to deal with day-to-
day issues must be addressed (the closest linac support
centre to Ghana is a 5-hour flight to South Africa).
However, remaining with cobalt-60 units is just not an
option. There are severe clinical disadvantages to
using such a low x-ray energy; dose cannot be
deposited at deep sites such as for cervical and
prostate treatments, particularly when considering the
larger size of Ghanaian patients, and such units do not
provide the skin sparing effect. Staff in the public
centres expressed their concern at the quality of
treatments and skin reactions resulting from the
equipment available at the public hospitals, with staff
morale being greatly affected. Providing them with the
opportunity to overcome these issues was met with
great interest, and they have made a running start to
address issues that have so far held them back: climate
(extremes of both humidity and dryness), environment
(an incredible amount of dust) and power (they now
boast a highly stable power generator). We hope that
the installation of linacs in Ghana will act as a test case
to demonstrate the training, maintenance and
protocols required for linac use in a developing
radiotherapy department.
In addition, many of the organisations who work in
the healthcare sector in developing countries speak out
about their desire for medical device manufacturers to
develop technology specifically for the developing
markets. This can be in the form of low-cost QA tools,
cheap, lower specification instrumentation, simple
screening technologies, and so on. Encouragingly
some of the major manufacturers are making a step in
that direction but for the coming years there will be an
urgent push for more.
The paRTner programme
We have learnt a lot and forged important individual,
hospital and governmental links during the first year of
paRTner; we are now in a position to transfer practical
support from UK medical physics and engineering to
Ghana. paRTner has secured a 2-year medical
equipment grant from the Tropical Health and
Education Trust (THET) to establish a training and
equipment maintenance programme in Ghana, and has
secured further funds from UCL Friends to improve
African cancer service provision. Following our fact-
finding trip we hosted the two senior medical
physicists, Eric Addison and Theophilus Sackey at RBH
and UCLH, in order to establish the steps needed for
the introduction of linac technology to Ghana. This UK
visit also enabled our Ghanaian colleagues to gain first-
hand experience of linac management and protocols,
and to meet with the Royal College of Radiologists to
start a dialogue for improvement of oncology services. 
Consideration of the most effective method of
training is key. The current training method, where
suitable candidates have to be sent abroad, has now
outlived its objective due to many reasons:
n The cost of training adequate staff in a dedicated
centre abroad to support a medium-sized radiotherapy
centre is enormous.
n Trainees do not receive the training designed to equip
them for work on return to their home countries, in
terms of using equipment they will routinely encounter,
rather than the sophisticated equipment in developed
countries, and focus on the diseases/situations
encountered locally.
n Trainees are not successful at the end of their
training, due to language and other cultural difficulties.
n Successful trainees are more likely to stay behind or
emigrate to other countries where they are likely to
obtain better career prospects than they would
otherwise obtain in their home countries. 
The above can be overcome through organisation of
local intensive training programmes, purposely
designed to be more relevant to the needs of individual
countries. Such an approach will be cheaper to run,
provide more training opportunities for many African
professionals and be likely to encourage personnel to
stay in their countries to develop local services.
With this in mind paRTner is offering help in the
form of mentoring and hands-on training in
conjunction with development of e-learning and
distance learning tools. A step-wise transfer of
knowledge will help them get to a position where they
are self-sufficient and have enough staff to provide a
service that is sustainable and successful. We will join
our Ghanaian colleagues in commissioning their first
linac and introducing their first quality system. For the
moment the treatments do not have to be of a complex
nature due to the late stages of cancer that are
presented but, in time, and with local education for the
population, they can develop into departments that can
join the international community of sophisticated
radiotherapy providers. Further initiatives include:
sending a team of skilled UK workers to Ghana for 2–4
weeks in the next 6 months to counter the most
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critical shortcomings in the cancer treatment delivery;
partnering Ghanaian radiotherapy medical physics and
engineering staff with UK counterparts who will remotely
assist with planning complex treatments, advise on quality
assurance testing and equipment faults, and advise on
procurement of new equipment; and put in practice an
engineering programme for preventative maintenance
whereby we aim to increase equipment uptime at each
centre to 90 per cent within 2 years (it is currently about 60
per cent).
This is an opportunity for experienced UK cancer professionals
to take part in something that has the potential to have huge
impact on patients and staff and to be exposed to patient
numbers and pathologies that are increasingly rare here (e.g.
cervical cancer), along with the opportunity to learn the basics of
radiotherapy in a challenging environment. Dr Matt Williams,
Clinical Oncologist, Imperial College Healthcare NHS
Trust
Equipment donation practices
As far as delivering a good radiotherapy service in Ghana,
the team require help in the form of equipment. Many UK
departments may well have old equipment that they
simply do not use any more but which could greatly
benefit the Ghanaian departments. paRTner will be
regularly touring the UK to collect any donated
equipment, big or small.
THET is currently preparing a good practice toolkit for
medical equipment donations to low-resource settings.
The primary audience for the toolkit is health partnerships
and other UK organisations that donate medical
equipment as part of their activities. The toolkit includes
good practice guidance for each stage of the donation
process, from initial discussions between donor and
recipient about what is required after donated equipment
arrives, is installed and ready for use. It includes in-depth
case studies, practical information about shipping and
customs logistics, and templates for donations paperwork.
Most importantly, it highlights what both donors and
recipients need to do to ensure that a donation will be
appropriate and useful for the recipient, as opposed to
burdensome. The toolkit will be formally launched in the
autumn of 2013. For more information visit
http://www.thet.org/hps/resources/ articles.
The Ghana Society for Medical Physics
As Dr Francis Hasford, Assistant Secretary of the society
explain, Medical physics training started locally in Ghana
in 2004. The programme has since produced 25 medical
physicists who are serving in the country’s radiotherapy,
nuclear medicine and diagnostic radiology, research and
tertiary institutions. The programme includes two
semesters of didactic education followed by 1 year of
research and clinical training. This is followed by a 1-year
internship covering radiation oncology, diagnostic
radiology and nuclear medicine at KBTH and/or KATH
for local graduates. The Medical Physics Department of
the Graduate School of Nuclear and Allied Sciences in the
University of Ghana is gradually becoming the hub of
medical physics training in the sub-region, attracting a
number of foreigners from some African countries. The
department currently hosts five IAEA fellows for
academic and radiotherapy clinical training. 
An infrastructure is in place at the Ghana Atomic
Energy Commission (GAEC) campus for academic
training of the medical physics students. In addition to
the research programmes of the individual lecturers,
GAEC’s Radiological and Medical Sciences Research
Institute (RAMSRI) has an active research programme in
place and students benefit from the Institute’s
programme with the research team leaders as supervisors
to deal with the research component of the academic
programme. RAMSRI is being nurtured into a complex,
composed of a hospital with a radiation emergency
medical facility and research centres promoting
indigeneous research with the main research activities in
medical diagnostic imaging and cancer treatment. This
project, when completed, would immensly contribute to
the training of medical physicist students since the
facility, which is to be cited very close to the medical
physics department, would serve as the official training
facility for students. Currently, some of the lecturers in
the department double as clinical medical physicists in
the oncology and nuclear medicine centres in the country.
This arrangement promotes good structure in conducting
clinical training with the lecturers having access to
facilities for training. 
The Medical Physics Department has been an
indispensable and strategic stakeholder in educational
and training programmes in the radiation sciences in the
country. Resource persons from the department have
been the backbone of the training programmes for
radiologists, radiographers, oncologists, dentists, nuclear
scientists and health physicists in addition to their core
business of providing training for medical physicists. The
faculty is staffed with competent, qualified and highly
motivated lecturers. There is a culture of continuing
education and skills upgrading in place, including
refresher courses and long-term training leading to PhD
degrees to promote research and clinical skills to offer the
best services.
The paRTner project is important to Ghana in the sense that it
would aid in improving radiotherapy services by training of
personnel, development of techniques and protocols, and
increasing capacity of equipment. This objective would be
achieved through (a) provision of resources in terms of
training, teaching, personnel and provision of equipment, (b)
location of funding for training support and assistance to help
Ghanaian radiotherapy departments secure funding internally,
(c) practical training courses tailored to local needs, (d)
collaborations between Ghanaian universities and hospital
departments, and between UK and Ghana universities. Ghana
Society for Medical Physics
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The journey ahead
The road ahead for Ghana’s developing radiotherapy
service is a challenging one. To reach the ultimate goal of
three to four treatment machines per million of
population requires not only huge investment but a huge
growth in qualified personnel and expansion of the
necessary infrastructure and nationwide organisation.
Those currently in the profession face an intensive
period of lobbying for further investment to meet future
demand, at the same time as increasing the number of
referrals through cancer awareness campaigns and
referral networks in order to create that future demand;
it’s a fine balance. But it is one that the UK and many
other countries have faced before, and look how far
we’ve come; so the road ahead need not be quite so
challenging because the template for development has
been set. Solutions to most of the future issues already
exist and this is where we see the potential benefits of a
UK–Ghana partnership, or a UK–any developing nation
partnership for that matter.
In the short term we can assist with the expansion of
the service through the arrival of the first linacs in the
public sector. In the medium term we can assist with
cancer awareness and education, training of future
workers to expand provision even further to meet the
predicted growth in demand, the integration of IMRT,
IGRT and other state-of-the-art methodologies into the
clinic, career development, and so on. And in the long
term we can assist with lobbying for further investment
to expand the service even further. There are large parts
of the country without any cancer service and only a
very small minority live within 1 hour of an oncology
department. Imagine if we could help to plant a
radiotherapy centre in the north of the country, with its
catchment population in excess of 10 million. The north
is a deprived region with no access at present to cancer
treatment, and it will also offer provision to Burkina
Faso.
The scope for a partnership of this type is vast
because of the multidisciplinary nature of the field, and
so, given the breadth and depth of UK expertise around
this area, we should be ambitious and aim high. For a
fledgling service with limited numbers of qualified
personnel the road ahead is challenging, as indeed it was
for the pioneers of the UK radiotherapy service. But, in
partnership with experienced, enthusiastic, UK
colleagues, who all have the benefit of hindsight, the
journey can become quicker and smoother. 
The paRTner project has proven to be a great success and is a
superb example of developing professional links to hospitals
and organisations beyond our traditional spheres of operation.
I am fully in support of any mechanism that permits an
extension of our competencies to those who could build upon
our success either in terms of clinical guidance or the creation
of professional standards. Perhaps of greater relevance, though,
is the improvement of healthcare for the population of Ghana
who was not only able to identify immediate benefits of the
exchange but also is enthusiastic to maintain an ongoing
relationship. Such an exchange of staff or ideas can only
provide benefits to all concerned including the Royal Berkshire
Hospital Cancer Centre and Medical Physics, and as
Departmental Director I am extremely enthusiastic for my
staff to reach out nationally and internationally to assist with
improvements in patient outcome. Professor Malcolm
Sperrin, Director of Medical Physics, RBH n
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Cases Number of patients %
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Ovary 42 3.8
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Wilms 8 0.7
Others 179 16
Total 1,118 100
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